Summary
Timber Pharmaceuticals is the subject of a merger offer by Danish LEO Pharma.
In two previous shareholder meetings, not enough shareholders voted to approve the offer.
If the merger with LEO Pharma is not…
Read more
If there’s one thing I’ve learned over the years in doing merger arbitrage in Australian companies, it is to always check the fine print. In quite a few small quirky Australian M&A deals, the ones…
Read more
Shares in battered biotech Tetraphase Pharmaceuticals (Nasdaq: TTPH) were yesterday’s big winner in US trading, moving up 78% after La Jolla (Nasdaq: LJPC) announced it had submitted a 22M non-binding all-cash proposal to acquire the…
Read more
Posera, a Canadian listed global provider of software solutions for the hospitality industry, is being acquired by PayFacto, a provider of payment solutions.
Posera is a nano-cap with a market capitalization of about 14 million…
Read more
Every now and then you encounter a situation in the (micro-cap) stock market that makes you wonder: am I wrong or is the market wrong?
Canada-listed The Intertain Group (TSE:ITX) is an indirect subsidiary of…
Read more
The Boards of both Anixter (NYSE: AXE) and Wesco (NYSE: WCC) won’t have time to celebrate Christmas at home this year. A bidding war to buy Anixter, a distributor of communication and security products, ensued…
Read more
A lot has already been written about the planned merger between Fiat Chrysler (NYSE: FCAU) (BIT: FCA) and French PSA Group (EPA: UG), to create the world’s fourth-largest automaker. The companies said last week they…
Read more
Eurocastle Investment (AEB: ECT) is a closed-end investment company, listed on Euronext Amsterdam. The company announced some time ago it will no longer seek material new investments, and will focus on distributing cash to shareholders…
Read more
